ERS Genomics Employee Directory
Biotechnology ResearchCalifornia, United States2-10 Employees
ERS Genomics, based in San Francisco, licenses the foundational CRISPR-Cas9 intellectual property developed by Emmanuelle Charpentier, providing access to researchers and companies across multiple fields of use. The organization draws on decades of genome editing and licensing experience to support development in therapeutics and related delivery technologies, spanning preclinical and clinical-stage programs. A notable development in 2026 is the launch of the Early Access Express License, aimed at helping early-stage innovators access the CRISPR/Cas9 portfolio at the earliest stages of development. The company has also pursued partnerships to broaden access to its patent portfolio, including an integration with Aurigene Pharmaceutical Services Limited announced in May 2026.
1-888-653-2347 
support@leadiq.com 
